Enasidenib is a prescription medication used to treat a type of blood cancer called relapsed or refractory acute myeloid leukemia (AML). It belongs to a class of drugs called kinase inhibitors and works by blocking the activity of a protein called isocitrate dehydrogenase-2 (IDH2), which is involved in the uncontrolled growth of cancer cells. Common side effects of Enasidenib include nausea, vomiting, diarrhea, fatigue, low white blood cell count, headache, and fever.
Enasidenib is a medication used to treat a specific type of leukemia known as acute myeloid leukemia (AML). It falls under a class of drugs called selective FLT3 inhibitors. Here's a deeper look at how it works and its uses:
Function: Enasidenib targets a specific genetic mutation (FLT3 mutation) in some AML cells. FLT3 is a protein that plays a role in the growth and survival of blood cells. In some cases, a mutation in this protein can cause abnormal growth of leukemia cells. Enasidenib works by inhibiting FLT3, thereby interrupting the growth and survival signals in AML cells with this specific mutation.
Use:
Enasidenib is approved for the treatment of adult patients with relapsed or refractory (not responding to standard treatment) AML who have a specific FLT3 mutation detected by a genetic test.
Important Considerations:
- Targeted Therapy: Enasidenib is a targeted therapy effective only for AML patients with the specific FLT3 mutation. A doctor will perform a genetic test to confirm the presence of this mutation before administering Enasidenib.
- Combination Therapy: Enasidenib is usually used in combination with other chemotherapy medications for AML treatment.
- Side Effects: Enasidenib can cause side effects, some of which can be serious. Common side effects include fatigue, nausea, diarrhea, headache, and fever. More serious side effects may include differentiation syndrome (a condition with skin rash, fever, and abnormal blood cell counts) and tumor lysis syndrome (a metabolic imbalance due to the rapid breakdown of cancer cells).
Brand Name:
Enasidenib is available under the brand name:
- Idhifa®
Disclaimer: This information is provided for educational purposes only and shouldn't be substituted for professional medical advice. Always consult your doctor for diagnosis, treatment recommendations, and potential side effects specific to your situation.